[HTML][HTML] Signaling pathways of chronic kidney diseases, implications for therapeutics

Q Yuan, B Tang, C Zhang - Signal transduction and targeted therapy, 2022 - nature.com
Chronic kidney disease (CKD) is a chronic renal dysfunction syndrome that is characterized
by nephron loss, inflammation, myofibroblasts activation, and extracellular matrix (ECM) …

[HTML][HTML] Kidney fibrosis: from mechanisms to therapeutic medicines

R Huang, P Fu, L Ma - Signal Transduction and Targeted Therapy, 2023 - nature.com
Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …

[HTML][HTML] Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment

L Chen, T Yang, DW Lu, H Zhao, YL Feng… - Biomedicine & …, 2018 - Elsevier
Chronic kidney disease (CKD) has emerged as a major cause of morbidity and mortality
worldwide. Interstitial fibrosis, glomerulosclerosis and inflammation play the central role in …

[HTML][HTML] Inhibition of Brd4 alleviates renal ischemia/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative …

H Liu, L Wang, X Weng, H Chen, Y Du, C Diao, Z Chen… - Redox biology, 2019 - Elsevier
Ischemia/reperfusion injury (I/R) is one of the leading causes of acute kidney injury (AKI) that
typically occurs in renal surgeries. However, renal I/R still currently lacks effective …

Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosis

AK Aranda-Rivera, A Cruz-Gregorio… - Free Radical Biology …, 2021 - Elsevier
Unilateral ureteral obstruction (UUO) is an experimental rodent model that mimics renal
fibrosis associated with obstructive nephropathy in an accelerated manner. After UUO, the …

Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation

MS Stratton, RA Bagchi, MB Felisbino… - Circulation …, 2019 - Am Heart Assoc
Rationale: Small molecule inhibitors of the acetyl-histone binding protein BRD4 have been
shown to block cardiac fibrosis in preclinical models of heart failure (HF). However, since the …

Chronic kidney disease: biomarker diagnosis to therapeutic targets

YN Wang, SX Ma, YY Chen, L Chen, BL Liu, QQ Liu… - Clinica Chimica …, 2019 - Elsevier
Chronic kidney disease (CKD), characterized as renal dysfunction, is recognized as a major
public health problem with high morbidity and mortality worldwide. Unfortunately, there are …

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

AP Jiménez-Uribe, T Gomez-Sierra, OE Aparicio-Trejo… - Cellular …, 2021 - Elsevier
The fibrotic process could be easily defined as a pathological excess of extracellular matrix
deposition, leading to disruption of tissue architecture and eventually loss of function; …

[HTML][HTML] Enhancer and super-enhancer dynamics in repair after ischemic acute kidney injury

J Wilflingseder, M Willi, HK Lee, H Olauson… - Nature …, 2020 - nature.com
The endogenous repair process can result in recovery after acute kidney injury (AKI) with
adaptive proliferation of tubular epithelial cells, but repair can also lead to fibrosis and …

Nox4 in renal diseases: An update

Q Yang, F Wu, J Wang, L Gao, L Jiang, HD Li… - Free Radical Biology …, 2018 - Elsevier
Reactive oxygen species derived from NADPH oxidase contribute to a wide variety of renal
diseases. Nox4, the major NADPH isoform in kidney, produces mainly H 2 O 2 that regulates …